Healthy Living/WellnessSarepta again seeks FDA approval for drug treating Duchenne muscular dystrophy Sarepta will file a new application for eteplirsen with the FDA. The eteplirsen drug will treat Duchenne muscular dystrophy, which affects young boys.by Anu Passary
Healthy Living/WellnessFDA cracks down on e-cigarette industry through new proposed regulationsby Vamien McKalin
Healthy Living/WellnessBeer price hike: New FDA rule to cost millions and raise beer pricesby Anne Francis
Healthy Living/WellnessUse of laparoscopic power morcellation for hysterectomy or fibroid removal may spread cancer: FDAby Anu Passary
Healthy Living/WellnessFDA approval of Tanzeum drug is good news for type 2 diabetes patientsby Jim Algar
Healthy Living/WellnessE-cigarettes attract youngsters using music festivals, tactics banned for traditional tobacco productsby Rhodi Lee
Healthy Living/WellnessPure honey vs. honey blend, FDA fights misbranding to protect consumersby Rhodi Lee
Healthy Living/WellnessFDA approves life-saving Evzio auto-injector for painkiller overdoseby Rhodi Lee
Healthy Living/WellnessCDC reports a sharp spike in e-cigarette poisonings over the past three yearsby Tabitha Laffernis
Healthy Living/WellnessFDA approves hay fever drug Oralair: Goodbye sneezing and allergy shots.by Rhodi Lee
Healthy Living/WellnessFDA advisers give thumbs up to MannKind's inhaled insulin drug for diabeticsby Maryanne Moll
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims